SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
Nature Medicine2017Vol. 23(8), pp. 975–983
Citations Over TimeTop 10% of 2017 papers
E. Kaitlynn Allen, Adrienne G. Randolph, Tushar Bhangale, Pranay Dogra, Maikke B. Ohlson, Christine M. Oshansky, Anthony E. Zamora, John P. Shannon, David Finkelstein, Amy Dressen, John P. DeVincenzo, Miguela A. Caniza, Ben Youngblood, Carrie M. Rosenberger, Paul G. Thomas
Related Papers
- → Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells(2017)38 cited
- → BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer(2023)15 cited
- → Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells(2012)32 cited
- → Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus(2020)6 cited
- → CTCF Promotes Long-range Enhancer-promoter Interactions and Lineage-specific Gene Expression in Mammalian Cells(2020)14 cited